Category - Hot Stocks

Daily Financial Update Opening Recap Market Pulse: Tech and crypto slid as AI-driven hype failed to deliver across U.S. earnings, shaking confidence just before the open. Bitcoin slid over 2%, pushing its monthly skid past 10%...

Overview: A Breakthrough Sparks an After-Hours Rally Anixa Biosciences, Inc. (NASDAQ: ANIX) is a clinical-stage biotech focused on cancer treatment and prevention. The company’s shares jumped over 15% after-hours on Dec 11, 2025...

Opening Recap Market Pulse: Asian equities climbed on fresh Fed rate-cut hopes while metals held mixed, setting a tone that hints at a stronger 2026 outlook. Key Movers: Sandip Sabharwal spots IndiGo’s pullback as a buy;...

Overview – Broad-Spectrum Vaccine Innovator Vaxcyte (Nasdaq: PCVX) is a clinical-stage vaccine company focused on next-generation pneumococcal conjugate vaccines (PCVs) that cover far more strains of pneumonia-causing bacteria...

Morning Snapshot Market Pulse: Asian equities slipped as foreign outflows hit the highest level since 2019, driven by anxiety over stretched tech valuations. The selloff looks deliberate rather than panicked, with big names in...

Mixed Martial Arts Group Limited (NYSE American: MMA) – doing business as MMA.INC – is an Australian-based tech platform aiming to unify the combat sports industry ([1]) ([1]). The company operates a digital ecosystem that...

Market Pulse: Tech enthusiasm nudged U.S. futures higher after global benchmarks closed mixed on Tuesday, setting a cautiously optimistic tone. Key Movers: SpaceX’s looming flotation hype and Starlink buzz fueled the rally, while...

Dividend Policy & History Ascentage Pharma Group International (NASDAQ: AAPG) is a clinical-stage biopharmaceutical company focused on oncology and related diseases ([1]). As is typical for growth-focused biotech firms, AAPG has...

Market Pulse: Markets drifted in place yesterday as U.S. and European shares barely budged, while Bitcoin peeled off exchanges in a long-term accumulation story that belies near-term bumpiness. Key Movers: Revolut’s 30%...

Company & Pipeline Overview Autolus Therapeutics (Nasdaq: AUTL) is a UK-based biotechnology company focused on CAR-T cell therapies for cancer and autoimmune diseases ([1]). The company recently transitioned to “early commercial...